Indolinone tyrosine kinase inhibitors block Kit activation and growth of small cell lung cancer cells.

Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors

1998 • 4,380 citations

Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.

1987 • 3,809 citations

The Molecular Genetics of Cancer

1987 • 1,729 citations

Tyrosine Kinase Inhibition: An Approach to Drug Development

1995 • 1,655 citations

[2] Protein kinase catalytic domain sequence database: Identification of conserved features of primary structure and classification of family members

1991 • 1,225 citations

Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.

1996 • 1,080 citations

SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.

1999 • 1,044 citations

Establishment and identification of small cell lung cancer cell lines having classic and variant features

1986 • 896 citations

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.

1995 • 895 citations

Stem Cell Factor and Hematopoiesis

1997 • 850 citations

The biology of stem cell factor and its receptor C-kit

1999 • 564 citations

SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.

2000 • 501 citations

Synthesis and Biological Evaluations of 3-Substituted Indolin-2-ones: A Novel Class of Tyrosine Kinase Inhibitors That Exhibit Selectivity toward Particular Receptor Tyrosine Kinases

1998 • 474 citations

Activating c-kit Gene Mutations in Human Germ Cell Tumors

1999 • 414 citations

Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization

1996 • 310 citations

Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor.

1996 • 275 citations

The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth.

2000 • 271 citations

Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer.

1991 • 258 citations

Design, Synthesis, and Evaluations of Substituted 3-[(3- or 4-Carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as Inhibitors of VEGF, FGF, and PDGF Receptor Tyrosine Kinases

1999 • 253 citations

Preferential expression of c-kit protooncogene transcripts in small cell lung cancer

1992 • 182 citations

Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors.

1991 • 180 citations

Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts

1993 • 164 citations

Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors.

1994 • 153 citations

Coexpression of the c-kit and stem cell factor genes in breast carcinomas.

1995 • 151 citations

Expression of stem cell factor and c-kit in human neuroblastoma. The Children's Cancer Group

1994 • 135 citations

Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors

1992 • 133 citations

Expression of stem cell factor and c-kit in human neuroblastoma. The Children's Cancer Group

1994 • 121 citations

ATP site-directed competitive and irreversible inhibitors of protein kinases

2000 • 117 citations

Steel Factor and c-kit Protooncogene: Genetic Lessons in Signal Transduction

1994 • 116 citations

c-kit Is Expressed in Soft Tissue Sarcoma of Neuroectodermic Origin and Its Ligand Prevents Apoptosis of Neoplastic Cells

1998 • 105 citations

c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.

1993 • 64 citations

Expression of c-<i>kit</i> and <i>kit</i> Ligand in Human Colon Carcinoma Cells

1993 • 52 citations

Indolinone Derivatives Inhibit Constitutively Activated KIT Mutants and Kill Neoplastic Mast Cells

2000 • 46 citations

Induction of apoptosis and inhibition of small cell lung cancer growth by the quinoxaline tyrphostins.

1997 • 33 citations

Protein kinase inhibitors: structural determinants for target specificity.

1998 • 32 citations